CBOE vs FATE · P/E 24, rev $2.72B vs rev $3.4M
Cboe Global Markets Inc (CBOE) versus Fate Therapeutics Inc (FATE) — a side-by-side from cached financials, not a winner call.
Cboe Global Markets Inc (CBOE) is a financial data & stock exchanges company listed on US.
Fate Therapeutics Inc (FATE) is a biotechnology company listed on US.
Latest reported CBOE revenue for 2026-06-30 was $2.72B. Net income was $738.8M. CBOE currently screens at market cap $29.50B and trailing P/E 24.1.
Latest reported FATE revenue for 2026-06-30 was $3.4M. Net income was -$61.4M. FATE currently screens at market cap $331.0M.
CBOE currently screens at market cap $29.50B and trailing P/E 24.1. FATE currently screens at market cap $331.0M.
Not investment advice. Open the CBOE and FATE stock pages for the full models.
Not investment advice.